456 related articles for article (PubMed ID: 25086330)
1. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X
Magn Reson Imaging; 2014 Dec; 32(10):1301-6. PubMed ID: 25086330
[TBL] [Abstract][Full Text] [Related]
2. Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence.
Liu Y; Li J; He N; Chen Y; Jin Z; Yan F; Haacke EM
Neuroimage; 2020 Sep; 218():116935. PubMed ID: 32413460
[TBL] [Abstract][Full Text] [Related]
3. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
[TBL] [Abstract][Full Text] [Related]
5. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
Prasuhn J; Prasuhn M; Fellbrich A; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Münte TF; Hanssen H; Heldmann M; Brüggemann N
Neurology; 2021 Sep; 97(10):e1007-e1016. PubMed ID: 34187859
[TBL] [Abstract][Full Text] [Related]
6. Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
Castellanos G; Fernández-Seara MA; Lorenzo-Betancor O; Ortega-Cubero S; Puigvert M; Uranga J; Vidorreta M; Irigoyen J; Lorenzo E; Muñoz-Barrutia A; Ortiz-de-Solorzano C; Pastor P; Pastor MA
Mov Disord; 2015 Jun; 30(7):945-52. PubMed ID: 25772492
[TBL] [Abstract][Full Text] [Related]
7. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.
Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
J Parkinsons Dis; 2015; 5(3):561-7. PubMed ID: 26406136
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.
Langley J; Huddleston DE; Liu CJ; Hu X
MAGMA; 2017 Apr; 30(2):121-125. PubMed ID: 27687624
[TBL] [Abstract][Full Text] [Related]
10. An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.
Liu Q; Wang P; Liu C; Xue F; Wang Q; Chen Y; Hou R; Chen T
BMC Neurol; 2023 Aug; 23(1):301. PubMed ID: 37580712
[TBL] [Abstract][Full Text] [Related]
11. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.
Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y
Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505
[TBL] [Abstract][Full Text] [Related]
12. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
[TBL] [Abstract][Full Text] [Related]
13. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
14. Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson's disease and essential tremor.
Wang X; Huang P; Haacke EM; Liu Y; Zhang Y; Jin Z; Li Y; Xu Q; Liu P; Chen S; He N; Yan F
Neuroimage Clin; 2023; 38():103420. PubMed ID: 37141646
[TBL] [Abstract][Full Text] [Related]
15. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.
Wolters AF; Heijmans M; Priovoulos N; Jacobs HIL; Postma AA; Temel Y; Kuijf ML; Michielse S
Neuroimage Clin; 2023; 39():103479. PubMed ID: 37494758
[TBL] [Abstract][Full Text] [Related]
16. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging.
Ohtsuka C; Sasaki M; Konno K; Kato K; Takahashi J; Yamashita F; Terayama Y
Parkinsonism Relat Disord; 2014 Jul; 20(7):755-60. PubMed ID: 24768616
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Azevedo P; Ferreira J; Abreu D; Gonçalves N; Nunes RG; Campos J; Ferreira JJ
Mov Disord; 2015 Jun; 30(7):953-9. PubMed ID: 25758364
[TBL] [Abstract][Full Text] [Related]
19. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging.
Moon WJ; Park JY; Yun WS; Jeon JY; Moon YS; Kim H; Kwak KC; Lee JM; Han SH
Korean J Radiol; 2016; 17(5):633-40. PubMed ID: 27587951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
